pollen from reaching the receptive stigmas, emasculated flowers were covered with a muslin bag for four days after pollination. Both the F1 and F2 generations were self-pollinated to produce F2 and F3 seed, respectively. Self-pollination was ensured by covering the flowers shortly before onset of anthesis with a muslin bag.
RNA isolation and cDNA synthesis Upper stems (defined as the 2 cm section immediately underneath the capsule) and whole capsules were harvested at two developmental stages represented by 1-3 days and 4-6 days, after petal fall. Five plants were used per developmental stage and cultivar. The material was ground to a fine powder in liquid nitrogen using a mortar and pestle. RNA was isolated from the powder using a CTAB-based extraction method (33) with small modifications: (i) three sequential extractions with chloroform:isoamylalcohol (24:1) were performed and (ii) the RNA was precipitated overnight with lithium chloride at 4°C. After spectrophotometric quantification, equal amounts of RNA were pooled from five plants per cultivar, development stage and organ. The pooled samples underwent a final purification step using an RNeasy Plus MicroKit (Qiagen, Crawley, UK). RNA was typically eluted in 30-100 µl water. cDNA was prepared with the SMART cDNA Library Construction Kit (Clontech, SaintGermainen-Laye, France) according to the manufacturer's instructions but using SuperScript II Reverse Transcriptase (Invitrogen, Paisley, UK ) for first strand synthesis. The CDSIII/3'PCR primer was modified to: 5' ATT CTA GAT CCR ACA TGT TTT TTT TTT TTT TTT TTT TVN 3' where R = A or G, V = A, C or G; N = A/T or C/G. Following digestion with MmeI (New England Biolabs, Hitchin, UK) the cDNA was finally purified using a QIAquick PCR Purification kit (Qiagen, Crawley, UK).
cDNA Pyrosequencing Pyrosequencing was performed on the Roche 454 GS-FLX sequencing platform (Branford, CT) using cDNA prepared from the following four samples of each of the three varieties:
i. upper stem, 1-3 days after petal fall ii. upper stem, 4 -6 days after petal fall iii. capsule, 1-3 days after petal fall iv. capsule, 4 -6 days after petal fall Raw sequence analysis, contiguous sequence assembly and annotation The raw sequence datasets were derived from parallel tagged sequencing on the 454 sequencing platform (34) .
Primer and tag sequences were first removed from all individual sequence reads. Contiguous sequence assembly was only performed on sequences longer than 40 nucleotides and containing less than 3% unknown (N) residues. Those high quality Expressed Sequence Tag (EST) sequences were assembled into unique contiguous sequences with the CAP3 Sequence Assembly Program (35) , and the resulting contigs were annotated locally using the BLAST2 program (36) against the non-redundant peptide database downloaded from the NCBI.
Expression profiling
The number of ESTs associated with a specific consensus sequence representing each of the candidate genes detailed in Figure 1 was counted for each EST library.
EST numbers were normalised on the basis of total number of ESTs obtained per library. For each variety, EST counts were combined for the two developmental stages from both stems and capsules. Differences in candidate gene expression levels between organs and varieties were visualised as a heat map using Microsoft Excel.
Preparation of genomic DNA from glasshouse grown plants In order to amplify and obtain genomic sequences of the candidate genes 30-50 mgs of leaf material was collected from 4-6 week old glasshouse-grown seedlings from each of the three varieties. Genomic DNA was extracted using the BioSprint 96 Plant kit on the BioSprint 96 Workstation (Qiagen, Crawley, UK) according to the manufacturer's protocol. Extracted DNA was quantified using Hoescht 33258 and normalized to 10 ng/ul. Amplification and sequencing of candidate genes from genomic DNA Primers for amplification and Sanger-sequencing of the candidate genes from genomic DNA were based on the respective contiguous sequences assembled from the ESTs or on BAC sequences. The primer sequences are shown in Table S8 . PCR amplifications were performed on pools of genomic DNA comprising DNA from four individuals. Amplification was typically carried out on 10 ng DNA extraction from the field-grown F2 mapping population 40-50 mg of leaf tissue was harvested from F2 plants at the 'small rosette' growth stage (~10 leaves present on each plant) into 1.2 ml sample tubes. A 3 mm tungsten carbide bead was added to each tube and samples were kept at -80°C for a minimum of two hours prior to freeze-drying for 18 hours. Following freeze drying, samples were powdered by bead-milling (Model TissueLyser, Qiagen, Hilden, Germany) at 30 Hz for two 60 s cycles separated by plate inversion. DNA extraction was performed with the Nucleospin Plant II kit (Macherey-Nagel, Düren, Germany) using the supplied Buffer Set PL2/3 following the manufacturer's protocol for centrifugal extraction. DNA was quantified by UV-spectroscopy.
Genotyping of the HN1×HM1 F2 mapping population for the presence or absence of the HN1-specific candidate genes Plants of the F2 mapping population were genotyped for the presence or absence of eight candidate genes. The gene primer pairs (Table S8) (Table S8) . Amplification products were diluted 1:20 in H 2 O and fractionated on an ABI 3730xl capillary sequencer (Applied Biosystems, Foster City, CA). Data were scored using GeneMarker™ software (Softgenetics, State College, PA).
Poppy straw analysis from field grown F2 plants Poppy capsules were harvested by hand from the mapping population once capsules had dried to approximately 10% moisture on the plant. After manually separating the seed from the capsule, the capsule straw samples (Poppy Straw) were then ground in a ball mill (Model MM04, Retsch, Haan, Germany) into a fine powder. Samples of ground poppy straw were then weighed accurately to 2 ± 0.003 g and extracted in 50 ml of a 10% acetic acid solution. The extraction suspension was shaken on an orbital shaker at 200 rpm for a minimum of 10 min, then filtered to provide a clear filtrate. The final filtrate was passed through a 0.22 µm filter prior to analysis. The loss on drying (LOD) of the straw was determined by drying in an oven at 105°C for 3 hours.
All solutions were analysed using a Waters Acquity UPLC system (Waters Ltd., Elstree, UK).
fitted with a Waters Acquity BEH C18 column, 2.1 mm × 100 mm with 1.7 micron packing. The mobile phase used a gradient profile with eluent A consisting of 10 mM ammonium bicarbonate of pH 10.2 and eluent B methanol. The mobile phase gradient conditions used are as listed in the table below with a linear gradient. The flow rate was 0.5 ml per minute and the column maintained at 60°C. The injection volume was 2 μl and eluted peaks were ionised in positive APCI mode and detected within 5 ppm mass accuracy using a Thermo LTQ-Orbitrap. The runs were controlled by Thermo Xcalibur software (Thermo Fisher Scientific Inc., Hemel Hempstead, UK). Mass spectra were collected over the 150-900 m/z range at a resolution setting of 7500. All data analysis was carried out in the R programming language in a 64-bit Linux environment (R 2.11).
Peak-picking was performed using the Bioconductor package, XCMS (37) , employing the centWave algorithm (38) . Redundancy in peak lists was reduced using the CAMERA package (39) . Alkaloids were identified by comparing exact mass and retention time values to those of standards and quantified by their pseudomolecular ion areas using custom R scripts.
Bacterial Artificial Chromosome (BAC) library construction The HN1 BAC library was constructed from high molecular weight (HMW) genomic DNA processed at Amplicon Express, Inc. ( Pullman, WA) from four week old seedlings using the method described (40 together encoded all 10 genes from the HN1 cluster, were selected for further sequence assembly (Table S5) . Where possible, gaps and ambiguous regions on both BAC clones were covered by primer walking with traditional Sanger sequencing to validate the assembly. Combination of the four overlapping BAC sequences gave a single continuous consensus sequence assembly of 401
Kb. The sequences of the 10 genes from the HN1 cluster were determined independently by Sanger sequencing and the 100% agreement of the Sanger determined gene sequences with the assembly from FGS provided quality assurance for the whole assembly. The sequences of the BAC clones PS_BAC193L09, PS_BAC179L19, PS_BAC150A23 and PS_BAC164F07 have been submitted to the GenBank of the National Centre for Biotechnology Information (www.ncbi.nlm.nih.gov/genbank/) and are available under the accession numbers JQ659010, JQ659009, JQ659011 and JQ659012, respectively.
Annotation of the assembled sequence The sequences of the four BAC clones were annotated with an automated gene prediction program FGENESH (42) . The gene structure including exonintron arrangement for the 10 genes in the HN1 cluster was validated by comparison with cDNA sequence for each gene (Table S5) . cDNA sequence was not available for any of the remaining ORFs detailed in Table S5 since they are not represented in any of our EST libraries. The predicted function of all ORFs was evaluated by BLAST analysis (36) and those ORFs with significant hits (e-value less than 1e -8 ) were included in Fig.3 . The assembled sequence of the whole 401 Kb HN1 gene cluster region was analyzed for repetitive/transposon content using the Repeatmasker program at http://repeatmasker.org .
Promoter region analysis The 1 Kb of DNA sequence upstream of the predicted start of translation for each of the 10 genes in the HN1 cluster were searched for the presence of plant cis-acting DNA elements using the PLACE database (20) . The results are shown in Table S6 .
Amino acid sequence alignment Multiple amino acid sequence alignment was performed using the ClustalW program (43) for each of the 10 genes in the HN1 cluster. The amino acid sequence encoded by each gene was compared against either the top hits from a BLAST search of the NCBI non-redundant protein database (36) or the protein sequences of functionally characterized homologues. In those cases were the predicted protein sequence for the 10 genes showed high similarity a combined ClustalW analysis was performed, for example in the case of PSMT2 and PSMT3. shaking for 1h at room temperature. Samples were then clarified by centrifugation and a 50 µl subsample diluted 10× in 1% acetic acid to give an alkaloid solution in 2% acetic acid for further analysis. All solutions were analyzed as described for the poppy straw analysis from field grown F2 plants. Likewise, all data analysis was carried out using the R programming language.
Generation of plasmid constructs for Virus Induced Gene Silencing (VIGS)
Putative alkaloid peaks were quantified by their pseudomolecular ion areas using custom scripts.
Peak lists were compiled and any peak-wise significant differences between samples were identified using 1-way ANOVA with p-values adjusted using the Bonferroni correction for the number of unique peaks in the data set. For any peak-wise comparisons with adjusted p-values < 0.05, Tukey's HSD test was used to identify peaks that were significantly different between any given sample and the control. Alkaloids were identified by comparing exact mass and retention time values to those of standards. Where standards were not available, the Bioconductor rcdk package (37) was used to generate pseudomolecular formulae from exact masses within elemental constraints C = 1 100, H = 1 200, O = 0 200, N = 0 3 and mass accuracy < 5ppm. The hit with the lowest ppm error within these constraints was used to assign a putative formula.
Cloning and heterologous expression of PSMT1 in Saccharomyces cerevisiae
Cloning and protein production in S. cerevisiae were performed using the pESC Yeast Epitope
Tagging System (Agilent Technologies, USA). The full-length coding sequence of PSMT1 was amplified from cDNA obtained from mRNA extracted from the HN1 variety using primers described in Table S8 . These primers introduced BamHI (forward primer) and XhoI sites (reverse primer) and the resulting PCR product was directionally cloned using the BamHI and XhoI sites of the pESC-TRP vector (Agilent Technologies, USA). The resulting pESC-TRP:PSMT1
construct was transformed into E. coli strain DH5α. Fidelity of the insert was confirmed by DNA sequencing.
Yeast transformation and protein production
pESC-TRP:PSMT1 was transformed into Saccharomyces cerevisiae strain G175 using the lithium acetate method following the protocol described by the manufacturer (Agilent Technologies, USA). Briefly, G175 strain was grown overnight in 50 mL YAPD broth (0.0075% following the cycling conditions described by the manufacturer.
Recombinant protein production was carried out following described methods (47) were harvested by centrifugation and a 2µL aliquot of supernatant analysed by UPLC-MS.
Supplementary Figures

Q39522.1 1 MCTSLSELKCPVFSTKRKLLLEFALRTSVDMAAQEGVNYLSGLG-LSRLICLPMALRAAIELNVFEIISQAGPDAQLSPSDIVAKIP--TKNPSAAISLDRILRMLGASS 107
ACL31653.1 1 ------------------------------MAAQEGVNYLSGLG-LSRLICLPMALRAAIELNVFEIISQAG-QMLNYHHQISSQNP--HENPSAAISLDRILRMLGASS 76
AAU20770.1 1 ------------------------------MALQEGVNYLSGLG-LSRLICLPMALRAAIELNVFEIIFQAGPEAQLSPAEIVAKIP--TKNPNAAIALDRILRMLGASS
77 PSMT1 1 ----MATNGEIFNTYGHNHQSATVTKITASNESSNGVCYLSETANLGKLICIPMALRAAMELNVFQLISKFGTDAKVSASEIASKMPNAKNNPEAAMYLDRILRLLGASS 106 CBI30956.3 1 -
-----------------------------MEGFDGSEYLSGWG--LSMIAVQMALKAAMELNVFNIIANAGPNAQLSCVEIVSKIP--TTNPNAAVALDRILRTLTFNS 76
XP_002280092.1 1 ------------------------------MEGFDGSEYLSGWG--LSMIAVQMALKAAMELNVFNIIANAGPNAQLSCVEIVSKIP--TTNPNAAVALDRILRTLTFNS 76
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Q39522.1 108 ILSVSTTKS------------GRVYGLNEESRCLVAS-EDKVSVVPMLLFTSDKAVVESFYNIKDVVLEEGVIPFDRTHGMDFFQYAGKEERVNKSFNQAMGAGSTIAFD 204
ACL31653.1 77 ILSVSTTKS------------GRVYGLNEESRCLVAS-EDKVSVVPMLLFTPDKAVVESFYNIKDVVLEEGVIPFDRTHGMDFFQYAGKEQRVNKSFNQAMGAGSTIAFD 173
AAU20770.1 78 ILSVTTMKD------------GRVYGLTEESRCLVAD-KNGVSVVPMLLFTSDKAVVESFYNIKDVVLEEGVIPFDRTHGMDFFAYAGKEQSVNKSFNQAMGAGSTIAFD
Q39522.1 314 VLPQVLGNNAESFNALTPDLLMMALNPGGKERTTIEFDGLAKAAGFAETKFFPISQGLHVMEFHKINC-----381
326 VLPNELGNNAESFNALIPDLLLMALNPGGKERTISEYDDLGKAAGFIKTIPIPISNGLHVIEFHK--------390 CBI30956. 3 292 AIPQVLGNDPPSLNATVADLYMMILNTGGKERTLAEFEHLAKAAGFAQTKVFPIAHGIHVIEFLKKRKKTSIN 364 XP_002280092.1 292 AIPQVLGNDPPSLNATVADLYMMILNTGGKERTLAEFEHLAKAAGFAQTKVFPIAHGIHVIEFLKSC------358 * *** * ** ** * ** ****** * * ***** * ** * ** ** * 
AAP45315.1 1 --------METVSKIDQQNQAKIWKQIYGFAESLVLKCAVQLEIAETLHNNVKPMS-LSELASKLPVAQPVNED--RLFRIMRYLVHMELFKID-----------ATTQK 88
AAQ01669.1 1 --------METVSKIDQQNQAKIWKQIYGFAESLVLKCAVQLEIAETLHNNVKPMS-LSELASKLPVAQPVNED--RLFRIMRYLVHMELFKID-----------ATTQK 88
ACO90232.1 1 --------METVSKIDQQNQAKIWKQIYGFAESLVLKCAVQLEIAETLHNNVKPMS-LSELASKLPVPQPVNED--RLFRIMRYLVHMELFKID-----------ATTQK 88 PSMT3 1 --------MEVVSKIDQENQAKIWKQIFGFAESLVLKCAVQLEIAETLHNNVKPMS-LSELASKLP-AQPVNED--RLYRILHFLVHMKLFNKD-----------ATTQK 87
119 GTNDKLFSNRPSSLAVKLMFYDTESYGFAPYGKYWRELRKISTHKLLS-NQQLEKFKHLRISEVDNSFKKLHELCSNNKQGGDTTYVASLVRMDDWFAYLTFNVIGRIVSGFQSNA----233 * * ** *** ** * * *
346 IALDMLSGGSDTTKLIMTWTLSLLLNHPDILDKAKEEVDTYFGKKKISDNTPVVDAADVPNLVYIQAIIKESMRLYPAS-TLMERMTSDDC-DVGGFHVPAGTRLWVNVWKMQRDPRVWK 463 * ** * * * * * * * * ** ** **** * * ** * * ** *
464 DPLVFLPERFLSN--DKGMVDVKGQNYELIPFGTGRRICPGASFALEVLHLVLTRLILEFEMKAP--EGKIDMRARPGFF-HNKVVPLDVQLTPRTLD------556 * * * * ** *** * * * * * * ** 
LGIAKFLLGKSSSSSLSTMEWPVGPKKLPIIGNLHQLGGD-VFHVVLANLAKVYGSVFTIWVGSWRPMIIVSDIDKAWEVLVNKSSDYSARD 106 1 ** ** ****** ** * * ** * * *** * * * * ** ********* ** 345 AVMKETMRMKPIAPMAIPHKTSKDTSLMGKKINKGSVIMVNLYAIHHNPKVFPEPYKFMPERFLKDVNSDESLGNIKTMESSLLAFSAGMRICAGMELGKLQLAFGLASLVHEFKWSCSV 464 209 * *********** ***** * *** * * *** * ** * ** **** * ** * * ******** ** **** * ** * *** * 293 
114 DFMM--KSDAHLSLLLPSEVAST---NFVKEAQVIVQVNMFDCGGTAICFCISNKIADA-CTMITFIRSLAGTTNIARRGSSIAAPTTNQNLVPSFDSTSLFPPSEQLAS-----QVSYP 222 Q94FT4. 1 115 EFMS--QPDVPLSQLLPSEVVSA---SVPKEALVIVQVNMFDCGGTAICSSVSHKIADA-ATMSTFIRSWASTTKTSRSGGSTAA-VTDQKLIPSFDSASLFPPSERLTSPSGMSEIPFS 227 AAC18062. 1 
QFLLG-EESNNLDLLVGLSGFLS---ETETPPLAAIQLNMFKCGGLVIGAQFNHIIGDM-FTMSTFMNSWAKACRVG----------IKEVAHPTFGLAPLMPSAKVLNIP---------198
AAF27621.1 112 VLGDLDDYSPSLEQLLFCLPPDT---DIEDIHPLVVQVTRFTCGGFVVGVSFCHGICDG-LGAGQFLIAMGEMARGE----------IKPSSEPIWKRELLKPEDPLYRFQYYHFQL---214
AAF34254.1 114 VLGDFDDSNPSFQQLLFSLPLDT---NFKDLSLLVVQVTRFTCGGFVVGVSFHHGVCDG-RGAAQFLKGLAEMARGE----------VKLSLEPIWNRELVKLDDPKY-LQFFHFEF---215 Q5Y9C7 114 VLGDLDDLNPSYEDLLYALPLNT---DIVNLYPLVVQVTRFACGGFVVGGSFHHSICDGPKALVNFCKALPD-GRGK----------DKLSCEPIWNRELLKPEDPIH-LQFYHLYS---215 CAD89104.2 107 QAIQNVVELEKLDQYLPSAAYPGGKIEVNEDVPLAVKISFFECGGTAIGVNLSHKIADV-LSLATFLNAWTATCRGET-----------EIVLPNFDLAARHFPPVDNTP----------204
AAG13130.1 106 DFLR-LRKIECLNEFVPIKPFSMEAISDERYPLLGVQVNVFDSG-IAIGVSVSHKLIDG-GTADCFLKSWGAVFRGCR----------ENIIHPSLSEAALLFPPRDDLPEKYVDQM---209
Q9ZTK5.1 110 DILKYELRSYARDLVLPKRVTVG-----SEDTTAIVQLSHFDCGGLAVAFGISHKVADG-GTIASFMKDWAASACYLSS--------SHHVPTPLLVSDSIFPRQDNIIC----------205
* * * * * 241 SMMLGVRLENAVHIDDVALAHIFVFECEKAKGRHICSSVDFPMHDLPKFISENYPEFNVPT-DLLKDIEEQ-EPVHLSSDKLLSMGFQFKYDFAEIFGDAIRCAKEKGFL----------348 AAB41550. 1 218 -EQIGVTRFHMVHVDDVARAHIYLLENSVPGGRYNCSPFIVPIEEMSQLLSAKYPEYQILTVDELKEIKGA-RLPDLNTKKLVDAGFDFKYTIEDMFDDAIQCCKEKGYL----------326 ** ** ** * ** ** ** * ** *** * ** *
PSAT1
-TQDSTSVDKLVSKRFVFDAAKITSAREKLQSLMHDK---YKCHRPTRVEVVSALIWKSAVKSAPP---------GSISTVTHAMNFRKKMDPP-LQDASFGNLCVVVTAVLPATTATTT 328
Q94FT4.1 228 STPEDTEDDKTVSKRFVFDFAKITSVREKLQVLMHDN---YKSRRQTRVEVVTSLIWKSVMKSTPA---------GFLPVVHHAVNLRKKMDPP-LQDVSFGNLSVTVSAFLPATTTTTT 334
AAC18062.1 198 -PPPSFEGVKFVSKRFVFNENAITRLRKEATEEDGDGDDDQKKKRPSRVDLVTAFLSKSLIEMDCAKKE---QTKSRPSLMVHMMNLRKRTKLA-LENDVSGNFFIVVNAESKITVAPKI 313
AAF27621.1 215 ICPP-STFGKIVQGSLVITSETINCIKQCLRE--------ESKEFCSAFEVVSALAWIARTRALQIP-------HSENVKLIFAMDMRKLFNPP-LSKGYYGNFVGTVCAMDNVKDLLSG 317
AAF34254.1 216 LRAP-SIVEKIVQTYFIIDFETINYIKQSVME--------ECKEFCSSFEVASAMTWIARTRAFQIP-------ESEYVKILFGMDMRNSFNPP-LPSGYYGNSIGTACAVDNVQDLLSG 318 Q5Y9C7 216 LCPSGPPIEKWVHASLVINPATIKCLKQSIME--------ECNEVCSSFEIMTALAWKARTKAFQIP-------QTQNVKLLFAVDMRKVFNPP-FPKGYYGNAIGFACAMDNAHDLING 319 CAD89104.2 204 -SPELVPDENVVMKRFVFDKEKIGALRAQASS-------ASEEKNFSRVQLVVAYIWKHVIDVTRAKYG-----AKNKFVVVQAVNLRSRMNPP-LPHYAMGNIATLLFAAVDAEWDKDF 310
AAG13130.1 209 -EALWFAGKKVATRRFVFGVKAISSIQDEAKS--------ESVPKPSRVHAVTGFLWKHLIAASRALTSG--TTSTRLSIAAQAVNLRTRMNMETVLDNATGNLFWWAQAILELSHTTPE 318
Q9ZTK5.1 205 --EQFPTSKNCVEKTFIFPPEAIEKLKSKAVEFG--------IEKPTRVEVLTAFLSRCATVAGKSAAKNNNCGQSLPFPVLQAINLRPILELP--QNSVGNLVSIYFSRTIKENDYLNE 313 * *
PSAT1
NPATKKVSSTSNEEQVALDELSDFVALLRREIDKVKGDKGCMEKIIQKFIYGHDASVAKDSDVEDKVTALFMTSWCKFGFYEADFGWGTPVWVTTVPL-----IEPKYKNMVFMNDMKCG 443
Q94FT4.1 335 NAVNKTINSTSSESQVVLHELHDFIAQMRSEIDKVKGDKGSLEKVIQNFASGHDASIKKINDVE--VINFWISSWCRMGLYEIDFGWGKPIWVTVDPN-----IKPN-KNCFFMNDTKCG 446
AAC18062.1 314 TDLTESLGSACGEIISEVAKVDDAEVVSSMVLNSVR-----------EFYYEWGKGEKN---------VFLYTSWCRFPLYEVDFGWGIPSLVDTT--------AVPFGLIVLMDEAPAG 405
AAF27621.1 317 -----SLLRVVRIIKKAKVSLNEHFT-STIVTPRSG--------------SDESINYEN---------IVGFGDRRRLGFDEVDFGWGHADNVSLVQHGLKDVSVVQSYFLFIRPPKNNP 408
AAF34254.1 318 -----SLLRAIMIIKKSKVSLNDNFK-SRAVVKPSE--------------LDVNMNHEN---------VVAFADWSRLGFDEVDFGWGNAVSVSPVQQ--QSALAMQNYFLFLKPSKNKP 407 Q5Y9C7
-----SLLHAVNIIRKAKAYLFEQCSKSSVAVNPSA--------------LDVNAGQES---------VVALTDWRRLGFNEVDFGWGDAVNVCPIQR-MTNGLVMPNYFLFLRPSEDMP 410 CAD89104.2 311 PDLIGPLRTSLEKTEDDHNHELLKGMTCLYELEPQE--------------------------------LLSFTSWCRLGFYDLDFGWGKPLSACTTTF--------PKRNAALLMDTRSG 390
AAG13130.1 319 IS-DLKLCDLVNLLNGSVKQCNGDYFETFKGKEGYG------------RMCEYLDFQRTMSSMEPAPDIYLFSSWTNF-FNPLDFGWGRTSWIGVAGK-----IESASCKFIILVPTQCG 419
Q9ZTK5.1 314 KEYTKLVINELRKEKQKIKNLSREKLTYVAQMEEFVKS---------LKEFDISNFLDID--------AYLSDSWCRFPFYDVDFGWGKPIWVCLFQP------YIKNCVVMMDYPFGDD
2O7R
MSNDHLETTGSSDPNTNLLKYLPIVLNPD-RTITRPIQ-IPSTAASPDP-----------TSSSPVLTKDLALNPLHNTFVRLFLPRHALYN----SAKLPLVVYFHGGGFILFSAASTI 103
NP_201024.1 1 MS----EPSPIADP----YAYLNIVNNPD-GSITRDLSNFPCTAATPDP-----------SPLNPAVSKDLPVNQLKSTWLRLYLPSSAVNEGNVSSQKLPIVVYYHGGGFILCSVDMQL 100
XP_003592370.1 1 MSGQPFSPEPIDP-----FLHLKITLNSN-GTITRLRE-DPHISPSSNP-----------NLPISVLTKDILINPSHNTSARIFLPRTALEH----ASKLPLIVYFHGGGFILFSAASDF 98
ABB89004.1 1 MADEPSSPNPAASID----LYKFILPNPD-GSLNRATPLFPIVPPTLTPPAESFRTKSNSNTPQLVLSKDIPLNPETKTFLRLFKPHPLPPN-----PHLALILYFHGGGFVLFSAASKP 110
XP_003627649.1 1 -----------MDP----YEFLKIKLNSD-GSLTRNYI-VPTVPSSSDPTN---------SPLQPALSKDIPLNAAAKTSIRLFLPNPPPSS---SAAKLPIILYFHGGGFILYHPSSLI 91 PSCXE1 1 ----------MADP----YEFLMCIHNPEEDTLTRNFP-IPATPLDQNT-------------------KDISLNPDRKTSLRIFRPPTKEPP-VTKNKLLPIIIYFHGGGFILFNADSTM 85 PSCXE2 1 ----------MADP----YEFLMCIHDPEEDTLTRNFP-IPATPLDQNT-------------------KDISLNLDRKTSLRIFRPPTEEFC-VTTNKLLPIIIYFHGGGFVLFNADSTI
26 AAR27014.1 1 ----------------MGSMAETVCVTGASGFIGSWLVMRLMERGYMVRATVR-DPENLKKVSHLLELPGAKGKLSLWKADLGEEGSFDEAIKGCTGVFHVATPMDFESKDPENEMIKPT 103 BAE19949.1 1 ----------------MGSVPETVCVTGAAGFIGSWLVMRLMERGYMVRATVR-DPANMKKVKHLLELPEAKTKLTLWKADLAEEGSFDEAIKGCTGVFHVATPMDFESKDPENEVIKPT 103 P93799 1 ----------------MGSQSETVCVTGASGFIGSWLVMRLLERGYTVRATVR-DPTNVKKVKHLLDLPKAETHLTLWKADLADEGSFDEAIKGCTGVFHVATPMDFESKDPENEVIKPT 103 ABQ97018.1 1 ---------------MVQDSPTTVCVTGAAGFIGSWLVMKLLQRGYTVRATVR-DPGNMKKVNHLIQLPKAKTNLTLWKADLTQEGSFDEAIEGCHGVFHVATPMDFESKDPENEIIKPT 104 PSSDR1 1 MHGQKNISERYQKFKEMEGTGKIVCVTGGAGYLASWLIMRLLERGYSVRTTVRSDPKFREDVSHLKALPEATEKLQIFEADLENPESFDDAINGCVGVFLVAQGMNFAEEYTLEKIIKTC 120 AAB41550.1 1 ---------------
AAR27014.1 334 ------334
BAE19949.1 336 K-----336 P93799
336 KT----337 ABQ97018. 1 337 DDHIHV 342 PSSDR1
348 ------348 AAB41550.1 326 ------326 Table S8 ; HyperLadder I (Bioline Reagents, London, UK) was used as molecular size standard. Cultures were grown as previously described (47) . Briefly, transformed cultures were grown on media containing glucose, washed and resuspended in 5mL induction medium in shake-flasks containing galactose with raffinose added as a carbon source. Six hours after induction, 15µM scoulerine was added to a subset of cultures. After 3 days, cultures were harvested by centrifugation and a 2µL aliquot of supernatant analysed by UPLC-MS. Off-set base peak chromatograms for the empty vector control and a representative assay are shown. Tetrahydrocolumbamine appeared in all four transformants and was not detectable in any controls (empty vector + substrate, wild-type ±substrate).
Fig. S10. Evidence for putative identities of intermediates from VIGS experiments.
All panels show the mass spectra of the pseudomolecular parent ion at the chromatographic peak apex in black and corresponding MS2 fragmentation spectra in red, scaled to relative abundance. MS2 spectra were generated by targeting the parent ion with a isolation width of 3 m/z and using collisional isolation dissociation energy set to 35%. All mass spectra were obtained at a resolution setting of 7500. Text printed above selected diagnostic ions indicate the exact monoisotopic mass of the ion, the calculated formula within limits C=1:100, O=0:200, N=0:3 and H=1:200, and the number/total number of formulae returned within a 5ppm error window. Fragments were reconciled against theoretical fragments generated by submitting candidate parent structures to Mass Frontier software (version 5.01.2; HighChem, Bratislava, Slovakia). Candidate parent structures were derived from PubChem searches and the comprehensive review of Papaver spp. alkaloids (48) . (A) Tetrahydrocolumbamine; this compound was characterized from a peak eluting at 174s from VIGS-silenced CYP719A21. Eight out of ten observed MS2 fragments were calculated as feasible by Mass Frontier; only the two most abundant diagnostic fragments are shown. (B) Secoberbine intermediate 1 (C21H25NO6); this compound was characterized from a peak eluting at 147s from VIGS-silenced CYP82X2. If R 1 =OH, R 2 =H, and R 3 =CH 2 OH, then this compound is narcotolinol which is consistent with both annotated fragments. Another candidate formula fit would be demethoxylated narcotindiol (R 1 =H, R 2 =OH, R 3 =CH 2 OH); however this structure would not form the observed fragment at 206.0816. (C) Secoberbine intermediate 2 (C21H23NO6); this compound was characterized from a peak eluting at 103s from VIGS-silenced CYP82X2. If R 1 =OH , R 2 =H, and R 3 =CHO, then this compound would be a desmethylated derivative of macrantaldehyde. (D) Papaveroxine; this compound was characterized from a peak eluting at 214s from VIGS-silenced PSCXE1. The 398.1600 fragment observed is consistent with deacetylation. (E) Narcotinehemiacetal; this compound was characterized from a peak eluting at 121s from VIGS-silenced PSSDR1. (F) Narcotoline (4'-desmethylnoscapine); this compound was characterized from a peak eluting at 208s from VIGS-silenced PSMT2. Other isobaric possibilities were 6-or 7-desmethylnoscapine. However, the 206.0816 fragment observed is consistent with a hydroxylated 4' position.
We were able to discount the alternative structures by comparing the candidate fragmentation spectra with that from synthetic 7-desmethylnoscapine, which eluted at a different retention time and lacked the characteristic 206.0816 fragment. Table S1 . High noscapine variety (HN1) specific metabolites. Metabolites were extracted from ground capsule-straw of field-grown high noscapine (HN1; n=28), thebaine (HT1; n=38) and morphine (HM1; n=36) varieties. Extracts were analysed by UPLC-MS, and a global MassTag peak list generated by the Bioconductor package, XCMS (37) . The global list was trimmed to remove background peaks, isotopes, adducts and fragments using custom R scripts and the CAMERA package (39) . The remaining peaks were annotated with calculated formulae and hits to known standards or putative compounds with matching candidate formulae. A total of 366 metabolites were reported as present (p < 0.05, ANOVA with Tukey's correction compared to a zero-value distribution), with 53 being HN1-specific. Above a threshold of 0.1% total profile, 10 metabolites were HN1-specific. = mass-to-charge (m/z) value (M) followed by retention time (T) in seconds; Formula hits 2 = number of formula hits returned within limits of C = 1:100, H=1:200,O=0:20, N=0:3 and 5ppm error; Formula 3 = calculated formula of assumed pseudomolecular ion; Metabolite ID 4 = matches to standards or putative hits to literature reported or hypothetical pathway compounds; Capsule yield 5 = where present morphine, codeine, oripavine, thebaine and noscapine are calculated using their respective standard curves and reported relative to dry weight. All other compounds were calculated using the thebaine standard curve. Values are means ± 1 standard deviation; Capsule profile 6 = individual metabolite yield / total metabolite yield x 100; p value 7 = ANOVA p-value result from HN1, HT1, HM1 comparisons where Tukeys's HSD correction was also < 0.05; Fold change 8 = minimum of HN1/HT1 or HN1/HM1 capsule yield value. All statistics and calculations were carried out using R 2.11. Table S3 . HN1-specific metabolites in the HN1 and HM1 x HN1 F1 generation. Metabolites were extracted from ground capsule straw as indicated in Fig. 2A . All metabolites that were absent in HM1 and significantly changed (p< 0.05, ANOVA with Tukey's HSD correction) in their % DW concentration between HN1 and the HM1 x HN1 F1 are tabulated. Table heading notes are  as per Table S1 . All HN1-specific metabolites except for salutaridinol-7-O-acetate were decreased in the F1realtive to HN1. Table S4 . Metabolites up-regulated in the HM1 x HN1 F1 generation relative to HM1. Metabolites were extracted from ground capsule straw as indicated in Fig. 2A . All metabolites that were significantly increased (p< 0.05, ANOVA with Tukey's HSD correction) in the HM1 x HN1 F1 % DW concentration relative to HM1 are tabulated. Table heading notes are as per Table S1 . Table S9 . Table S6 . Elements identified in the promoter region of the ten cluster genes (provided as separate Excel file). The 1Kb upstream region relative to the start of translation for each gene was compared against the PLACE database (20). Table S8 . Primer sequences and associated information (provided as separate Excel file). Table S9 . Text file of the 401 Kb region of genomic DNA depicted in Fig. 3 and detailed in Table S5 . Gaps representing short highly repetitive regions are denoted by a sequence of 100 Ns and are detailed further in the NCBI accessions.
